Alcon PE Ratio 2019-2022 | ALC

Current and historical p/e ratio for Alcon (ALC) from 2019 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Alcon PE ratio as of September 23, 2022 is 24.91.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Alcon PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-09-23 60.02 65.24
2022-06-30 69.89 $0.92 75.97
2022-03-31 79.33 $0.93 85.30
2021-12-31 87.12 $0.76 114.63
2021-09-30 80.47 $0.67 120.10
2021-06-30 70.26 $0.37 189.89
2021-03-31 70.18 $-0.80 0.00
2020-12-31 65.98 $-1.09 0.00
2020-09-30 56.95 $-1.47 0.00
2020-06-30 57.32 $-1.31 0.00
2020-03-31 50.82 $-1.25 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $29.415B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.040B 20.78
Edwards Lifesciences (EW) United States $52.534B 37.17
STERIS (STE) Ireland $16.731B 20.78
Teleflex (TFX) United States $9.732B 15.51
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Glaukos (GKOS) United States $2.385B 0.00
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.035B 15.85
Artivion (AORT) United States $0.537B 51.19